Gerber, David E.
Harold C. Simmons Comprehensive Cancer Center, Dallas,
United States
2025 Rank: 18,159
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 531 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18,159 | 19,753 |
| Total Cites | 1,908 | 1,994 |
| H-index | 18 | 18 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 36 | 37 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 185 | 197 |
| Number of Single+First+Last Authored Papers | 165 | 165 |
| Total Cites to Single+First+Last Authored Papers | 526 | 562 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,731 | 1,776 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.12 |
| Self-Citation Percentage |
4.31%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 513 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15,741 | 16,702 |
| Total Cites | 2,097 | 2,195 |
| H-index | 17 | 17 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 31 | 32 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 190 | 202 |
| Number of Single+First+Last Authored Papers | 152 | 152 |
| Total Cites to Single+First+Last Authored Papers | 552 | 588 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,834 | 1,892 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
4.46%
|
|
Gerber, David E.
Harold C. Simmons Comprehensive Cancer Center, Dallas,
United States
2023 Rank: 13,800
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 505 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13,800 | 13,025 |
| Total Cites | 2,227 | 2,382 |
| H-index | 18 | 19 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 42 | 45 |
| Number of Single+First Authored Papers | 66 | 66 |
| Total Cites to Single+First Authored Papers | 195 | 222 |
| Number of Single+First+Last Authored Papers | 143 | 143 |
| Total Cites to Single+First+Last Authored Papers | 489 | 564 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,978 | 2,050 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.16 |
| Self-Citation Percentage |
6.51%
|
|
Gerber, David E.
Harold C. Simmons Comprehensive Cancer Center, Dallas,
United States
2022 Rank: 13,808
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 516 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13,808 | 13,958 |
| Total Cites | 2,185 | 2,304 |
| H-index | 17 | 18 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 35 | 37 |
| Number of Single+First Authored Papers | 61 | 61 |
| Total Cites to Single+First Authored Papers | 226 | 243 |
| Number of Single+First+Last Authored Papers | 126 | 126 |
| Total Cites to Single+First+Last Authored Papers | 506 | 538 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,937 | 2,017 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
5.16%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 573 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15,676 | 15,500 |
| Total Cites | 3,271 | 3,454 |
| H-index | 20 | 21 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 45 | 47 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 308 | 336 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 686 | 756 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,919 | 3,030 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.14 |
| Self-Citation Percentage |
5.30%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 650 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 17,999 | 19,987 |
| Total Cites | 2,466 | 2,619 |
| H-index | 16 | 17 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 37 | 37 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 189 | 206 |
| Number of Single+First+Last Authored Papers | 101 | 101 |
| Total Cites to Single+First+Last Authored Papers | 422 | 469 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,183 | 2,279 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
5.84%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.